AFP and neoplasm: The 2 groups had no significant differences in sex, age, ECOG score, preoperative antiviral therapy, alanine transaminase (ALT), alpha-fetoprotein (AFP), vitamin K absence-II (PIVKA-II), tumor diameter, number of tumors >3, type III portal vein tumor thrombus (PVTT), BCLC stage, Child-Pugh score, or local therapy (P > .05).